A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan
暂无分享,去创建一个
M. Sata | S. Kaneko | N. Izumi | Y. Shiratori | N. Sato | H. Saito | M. Omata | H. Yoshida | Kazuyuki Suzuki | M. Onji | M. Moriyama | Y. Kohgo | Kyosuke Yamamoto | H. Takagi | S. Nishiguchi | A. Shibuya | S. Hige | Y. Iwasaki